TransDigm CFO Sarah Wynne receives 15,150 stock options

The award has performance-conditioned exercisability milestones beginning September 30, 2027, with later installments on September 30, 2030, and September 30, 2031.

Available on EDGAR 11/05/2026 - 05:14 PM EST Accepted by SEC EDGAR 11/05/2026 - 05:13 PM EST Learn about SEC filing dates

Rhea-AI Filing Summary

TransDigm Group Chief Financial Officer Sarah Wynne acquired a direct award of 15,150 stock options on November 3, 2026, covering common stock at an exercise price of $1,208.04 per share and expiring November 3, 2036. The reported resulting option position was 15,150 options. Of the award, 4,700 options are exercisable at 20% per year over five years beginning September 30, 2027, subject to annual operating performance targets each year; 10,450 options are exercisable in two equal installments on September 30, 2030, and September 30, 2031, subject to the same targets.

Insider Trade Summary

Grant/Award: 15,150 shares

Grant/Award 1 txn

Insider Wynne Sarah

Role Chief Financial Officer

Type	Security	Shares	Price	Value
Grant/Award	Stock Option F1	15,150	$0.00	$0.00

Holdings After Transaction: Stock Option — 15,150 contracts (Direct)

Footnotes (1)

1. F1. 4,700 options are exercisable at 20% per year over five years beginning September 30, 2027, subject to achievement of annual operating performance targets each year. 10,450 options are exercisable in two equal installments on September 30, 2030, and September 30, 2031, subject to achievement of annual operating performance targets each year.

Key Figures

Stock options awarded: 15,150 options Exercise price: $1,208.04 per share Options following award: 15,150 options +3 more

6 metrics

Stock options awarded 15,150 options Awarded November 3, 2026

Exercise price $1,208.04 per share Options covering common stock

Options following award 15,150 options Reported resulting option position

First exercisability tranche 4,700 options 20% per year over five years beginning September 30, 2027, subject to annual operating performance targets each year

Second exercisability tranche 10,450 options Two equal installments on September 30, 2030, and September 30, 2031, subject to annual operating performance targets each year

Expiration date November 3, 2036 Stock options

Key Terms

exercisable, annual operating performance targets, equal installments

3 terms

exercisable financial

"4,700 options are exercisable at 20% per year over five years"

annual operating performance targets technical

"subject to achievement of annual operating performance targets each year"

equal installments financial

"10,450 options are exercisable in two equal installments"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many options did TDG CFO Sarah Wynne receive, and what is the exercise price?

Sarah Wynne received 15,150 stock options on November 3, 2026, with an exercise price of $1,208.04 per share. The options cover TransDigm Group common stock and expire November 3, 2036.

When do Sarah Wynne's TDG options become exercisable?

The 4,700-option tranche is exercisable at 20% per year over five years beginning September 30, 2027, subject to achievement of annual operating performance targets each year. The other 10,450 options are exercisable in two equal installments on September 30, 2030, and September 30, 2031, subject to the same annual targets.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Wynne Sarah

(Last) (First) (Middle)

1350 EUCLID AVENUE

SUITE 1600

(Street)

CLEVELAND OHIO 44115

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
TransDigm Group INC [ TDG ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
11/03/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option	$1,208.04	11/03/2026		A		15,150		(1)	11/03/2036	Common Stock	15,150	$0.00	15,150	D

Explanation of Responses:

1. 4,700 options are exercisable at 20% per year over five years beginning September 30, 2027, subject to achievement of annual operating performance targets each year. 10,450 options are exercisable in two equal installments on September 30, 2030, and September 30, 2031, subject to achievement of annual operating performance targets each year.

Remarks:

	/s/ Rachel L. Quinlan as attorney in fact for Sarah Wynne	11/05/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)